Polls

Practice Management: What Would You Like to Know?
Submit your questions on practice management, from coding and billing to marketing and referrals, to guide our new initiatives with real-world examples and help move dermatology forward.
Poll: Hidradenitis Suppurativa Comorbidities
Do you routinely screen for these diseases in your patients with HS? Let us know in the poll below!
Survey: Social Media in Dermatology
Poll: Which Cancer Staging System Do You Use?
Which staging system for risk stratification of cutaneous malignancies does your practice use? Let us know in this poll!
Poll: What Topics Would You Like to See in 2021?
Submit your answers to our poll.
Poll: Mental Health and Psoriasis
Do you consider mental health in the treatment plan for your patients with psoriasis? Let us know in the poll below!
Reader Survey: Aesthetics
The Dermatologist is s planning its 2021 editorial calendar, and we want to hear from you. When it comes to aesthetics, what topics would you like to see us cover? Let us know in the poll below!
Poll: Biologic Efficacy
A recent meta-analysis reviewed the latest evidence on efficacy and tolerability of the available biologic agents for the treatment of moderate to severe plaque psoriasis. Do you agree with their results? Let us know!
You Make the Call: Psoriasis Edition
In this edition of You Make the Call, your patient presents with worsening plaque psoriasis (>8% BSA) now affecting his scalp and bilateral upper extremities after failing effective treatment with narrowband UV-B and topical corticosteroid combination therapy. How would you approach treatment?
Poll: What Factor is Most Important to Consider When Starting a Biologic?
The decision to start a patient with psoriasis onto a systemic agent for disease management is an important conversation between provider and patient. When considering a biologic for the treatment of plaque psoriasis, what is the most important factor in your clinical decision?
Back to Top